(Reuters) – Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan.
See Original Article
Welcome to The Weekly Fix, the newsletter that’s still working on its poker face. I’m cross-asset reporter Katie Greifeld. Don’t Call it a Policy Error. Another week, another surprisingly intense Treasury rally. Yields on 10-year Treasuries are set to drop for a third …
See Original Article
Follow @crypto Twitter for the latest news. Bitcoin has been grinding lower in a trading range just above $30,000, prompting cryptocurrency insiders to flag the round number as a potential floor for the virtual coin. Crypto prognostication is fraught with risk, not …
See Original Article
BANGKOK (AP) â Shares opened higher in Europe on Friday after a mixed day of trading in Asia, where rising coronavirus cases and the risks to pandemic recoveries weighed on sentiment.
See Original Article
State-owned oil giant China Petroleum & Chemical Corp., known as Sinopec, and China Energy Investment Corp., one of the world’s top coal producers, were among companies to join the start of trading Friday, when carbon allowances rose to a 10% daily limit …
See Original Article
Leave a Reply